Stories from The University of Texas Health Science Center at Houston (UTHealth Houston)
June 29, 2022
Providing caregivers easy access to produce and flexible resources can lead to improvements in kids’ diets in a short time, according to a new study co-authored by researchers with UTHealth School of Public Health together with researchers from Dell Medical School at The University of Texas at Austin.
June 28, 2022
As a stay-at-home father of three, Jordan Gonzales was determined to tackle his Type 2 diabetes to be a healthy and present parent.
June 28, 2022
A large multicenter, randomized clinical trial revealed no difference in the risk of endotracheal intubation requirement at 30 days between awake prone positioning and standard positioning for patients with COVID-19 who suffered from acute hypoxemic respiratory failure, according to research published in JAMA by researchers at UTHealth Houston.
June 24, 2022
People who received at least one influenza vaccine were 40% less likely than their non-vaccinated peers to develop Alzheimer’s disease over the course of four years, according to a new study from UTHealth Houston.
June 22, 2022
Daily use of a mushroom extract supported the immune system in clearing human papillomavirus (HPV) infections, according to researchers with UTHealth Houston. The study was published today in Frontiers in Oncology.
June 17, 2022
In 2014, a dysautonomia diagnosis led 6-year-old Hannah Haisler of Belton, Texas, to Mohammed T. Numan, MD, with the Dysautonomia Center for Excellence at UTHealth Houston. Today, the 14-year-old is playing competitive volleyball and bungee jumping, thanks to the care she received.
June 16, 2022
A new study shows targeting a protein in smooth muscle cells can block and decrease buildup of atherosclerotic plaque in mouse models, according to researchers with UTHealth Houston.
June 15, 2022
Some patients with obstructive sleep apnea (OSA) who don’t respond to traditional therapy are benefiting from an alternative option being offered at UTHealth Houston.
June 7, 2022
A state-of-the-art mobile simulation training unit designed to enhance high-level adult and pediatric emergency medicine care is coming to UTHealth Houston.
May 31, 2022
Adults infected with COVID-19 develop circulating antibodies that last for nearly 500 days, according to a new study led by researchers at UTHealth School of Public Health.
The findings were published in The Journal of Infectious Diseases.
Use the form below to perform a new search.